(Q46736590)

24 December 2017

title

The serotonergic hypothesis for depression in Parkinson's disease: an experimental approach (English)

1 reference

24 December 2017

1 reference

4

Frans R J Verhey

1 reference

24 December 2017

author name string

Albert F G Leentjens

series ordinal

1

1 reference

24 December 2017

Bart Scholtissen

series ordinal

2

1 reference

24 December 2017

Fred W Vreeling

series ordinal

3

1 reference

24 December 2017

language of work or name

English

0 references

publication date

1 May 2006

1 reference

24 December 2017

published in

Neuropsychopharmacology

1 reference

24 December 2017

volume

31

1 reference

24 December 2017

issue

5

1 reference

24 December 2017

page(s)

1009-1015

1 reference

24 December 2017

Serotonergic 'vulnerability' in affective disorder: a study of the tryptophan depletion test and relationships between peripheral and central serotonin indexes in citalopram-responders

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300914

An Inventory for Measuring Depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300914

Staging of brain pathology related to sporadic Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300914

Tryptophan depletion during continuous CSF sampling in healthy human subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300914

Post-synaptic 5-HT1A and 5-HT2A receptors are increased in Parkinson's disease neocortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300914

Pramipexole augmentation of a selective serotonin reuptake inhibitor in the treatment of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300914

Serotonin function and the mechanism of antidepressant action. Reversal of antidepressant-induced remission by rapid depletion of plasma tryptophan.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300914

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300914

Selective serotonin-reuptake inhibitor-induced movement disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300914

Motor effects of serotonin in the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300914

Preliminary randomized, double-blind, placebo-controlled trial of pramipexole added to mood stabilizers for treatment-resistant bipolar depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300914

A rating scale for depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300914

Measuring the impact of Parkinson's disease with the Parkinson's Disease Quality of Life questionnaire.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300914

Parkinsonism: onset, progression, and mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300914

5-HT and motor control: a hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300914

Pathology of Parkinson's disease. Changes other than the nigrostriatal pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300914

Noradrenaline and 5-hydroxytryptamine modulation of brain dopamine function: implications for the treatment of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300914

5-hydroxyindoleacetic and homovanillic acid levels in the cerebrospinal fluid of healthy volunteers and patients with Parkinson's syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300914

Effects of tryptophan depletion on anxiety and on panic provoked by carbon dioxide challenge.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300914

Mood effects of 24-hour tryptophan depletion in healthy first-degree relatives of patients with affective disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300914

Specificity of the tryptophan depletion method

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300914

Prolactin and cortisol responses to fenfluramine in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300914

Compulsive use of dopamine replacement therapy in Parkinson's disease: reward systems gone awry?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300914

Depression in Parkinson's disease: conceptual issues and clinical challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300914

SSRIs in the treatment of depression in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300914

Higher incidence of depression preceding the onset of Parkinson's disease: a register study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300914

Tryptophan depletion, executive functions, and disinhibition in aggressive, adolescent males.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300914

Movement Disorders Associated With the Serotonin Selective Reuptake Inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300914

The correlation of depression with functional activity in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300914

Altered serotonin metabolism in depressed patients with parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300914

Serotonergic dysfunction in depression associated with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300914

Tryptophan depletion in normal volunteers produces selective impairment in memory consolidation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300914

Reduction of cortical dopamine, noradrenaline, serotonin and their metabolites in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300914

Serotonergic mechanisms in Parkinson's disease: opposing results from preclinical and clinical data

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300914

Effects of acute tryptophan depletion on mood and cortisol release in first-degree relatives of type I and type II bipolar patients and healthy matched controls.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300914

Neuropsychological impairment in Parkinson's disease with and without depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300914

Central serotonin metabolism and frequency of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300914

Effects of acute tryptophan depletion on plasma and cerebrospinal fluid tryptophan and 5-hydroxyindoleacetic acid in normal volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300914

A population perspective on diagnostic criteria for Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300914

Defective 5-HT1 -Receptor-Mediated Neurotransmission in the Control of Growth Hormone Secretion in Parkinson’s Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300914

ACTH/Cortisol Involvement in the Serotonergic Disorder Affecting the Parkinsonian Brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300914

The Neurobiological Substrates of Depression in Parkinson’s Disease: A Hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300914

7 January 2021

Ventilatory effects of tryptophan depletion in panic disorder: a preliminary report

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300914

7 January 2021

Depression and Parkinson's disease: possible role of serotonergic mechanisms

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300914

7 January 2021

Depression in Parkinson's disease: biogenic amines in CSF of "de novo" patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300914

7 January 2021

Markers for depression in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300914

7 January 2021

Identifiers

DOI

10.1038/SJ.NPP.1300914

1 reference

24 December 2017

1 reference

24 December 2017